What are the American Diabetes Association (ADA) diagnostic criteria for diabetes and prediabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ADA Diabetes and Prediabetes Diagnostic Criteria

The American Diabetes Association recognizes four distinct criteria for diagnosing diabetes, any one of which is sufficient: fasting plasma glucose ≥126 mg/dL, 2-hour plasma glucose ≥200 mg/dL during a 75-g oral glucose tolerance test, hemoglobin A1c ≥6.5%, or random plasma glucose ≥200 mg/dL with classic symptoms of hyperglycemia. 1, 2

Diabetes Diagnostic Criteria

The diagnosis of diabetes requires meeting any one of the following thresholds 1:

  • Fasting plasma glucose (FPG) ≥126 mg/dL (7.0 mmol/L) after at least 8 hours of overnight fasting 1, 2
  • 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during a 75-g oral glucose tolerance test (OGTT) performed after an overnight fast of at least 8 hours 1, 2
  • Hemoglobin A1c ≥6.5% (48 mmol/mol), measured in a laboratory using an NGSP-certified method standardized to the DCCT assay 1, 2
  • Random plasma glucose ≥200 mg/dL (11.1 mmol/L) in a patient with classic symptoms of hyperglycemia (polyuria, polydipsia, polyphagia, unexplained weight loss) 1, 2

Confirmation Requirements

Two abnormal test results are required to confirm the diagnosis of diabetes, obtained either from the same sample or from tests performed on different days. 1 The critical exception is when a patient presents with unequivocal hyperglycemia (glucose ≥200 mg/dL) accompanied by classic symptoms—this single finding confirms diabetes immediately without requiring repeat testing. 1 Alternatively, if two different tests (such as A1c and FPG) are both above their respective diagnostic thresholds, this also confirms the diagnosis. 2

Prediabetes Diagnostic Criteria

Prediabetes is identified by any one of three criteria: impaired fasting glucose (100-125 mg/dL), impaired glucose tolerance (140-199 mg/dL at 2 hours during OGTT), or A1c between 5.7% and 6.4%. 1, 2

The specific thresholds are 1, 2, 3:

  • Impaired fasting glucose (IFG): FPG 100-125 mg/dL (5.6-6.9 mmol/L) 1, 3
  • Impaired glucose tolerance (IGT): 2-hour plasma glucose 140-199 mg/dL (7.8-11.0 mmol/L) during a 75-g OGTT 1, 3
  • A1c: 5.7-6.4% (39-47 mmol/mol) 1, 2, 3

Important Caveats for Prediabetes Diagnosis

A1c should be used only for screening for prediabetes; the actual diagnosis of prediabetes should be confirmed with glucose testing (either FPG or OGTT). 1 This distinction is critical because A1c has lower sensitivity and may miss individuals who would be identified by glucose-based criteria. 4

Critical Testing Considerations

A1c Limitations

When using A1c for diagnosis, recognize several important limitations that may affect accuracy 2:

  • Hemoglobin variants can interfere with A1c measurement, though most U.S. assays are unaffected by common variants 2
  • Conditions with increased red blood cell turnover (sickle cell disease, pregnancy in second/third trimesters, hemodialysis, recent blood loss or transfusion, erythropoietin therapy) require using only plasma glucose criteria for diagnosis 2
  • Age and race/ethnicity may independently affect hemoglobin glycation 2
  • Point-of-care A1c assays should not be used for diagnosis—only laboratory measurements using NGSP-certified methods are acceptable 5, 2

Screening Recommendations

All adults ≥35 years of age with risk factors should be screened for diabetes. 1 For adults without risk factors, screening should begin at age 45 years. 2 If results are normal, repeat testing at minimum 3-year intervals, with more frequent testing based on initial results and risk status. 2

Patients with prediabetes should be tested annually to monitor for progression to diabetes. 2

Algorithmic Approach to Diagnosis

  1. If symptomatic (polyuria, polydipsia, weight loss): Obtain random plasma glucose—if ≥200 mg/dL, diabetes is confirmed immediately 1, 2

  2. If asymptomatic: Obtain any one of the following tests 1, 2:

    • Fasting plasma glucose (preferred for simplicity)
    • A1c (convenient, no fasting required)
    • 2-hour OGTT (most sensitive but cumbersome)
  3. If first test is abnormal (but patient is asymptomatic): Confirm with a second abnormal test result, either repeating the same test on a different day or using a different diagnostic test 1, 2

  4. If values fall in prediabetes range: Confirm with glucose testing (FPG or OGTT) rather than relying on A1c alone 1

The most practical approach in clinical practice is to use fasting plasma glucose as the initial screening test due to its simplicity, reproducibility, and patient acceptability, reserving OGTT for cases where clinical suspicion remains high despite normal FPG. 5, 6

Related Questions

What are the current Philippines clinical practice guideline recommendations for managing diabetes in adults?
What is the recommended treatment for diabetic dermatitis in a patient with diabetes?
Can I give intravenous ceftriaxone to an uncontrolled diabetic patient with an infected foot wound?
How long after stopping glipizide will its glucose-lowering effect wear off?
Is it safe to increase my twice-daily basal insulin glargine (Lantus) from 15 units each dose to 20–25 units each dose in uncontrolled diabetes mellitus?
Why did my patient’s ADHD stimulant lose effectiveness after one month of tirzepatide (Zepbound) therapy, and which alternative stimulant (e.g., dexedrine [dextroamphetamine], focalin [dexmethylphenidate], ritalin [methylphenidate]) is appropriate given that insurance does not cover concerta or strattera?
Should a patient who has been on Adderall XR 30 mg daily, Adderall IR 30 mg twice daily for two months, and a trial of Vyvanse, reduce the Adderall dose to a starting dose of 5 mg immediate‑release?
Can patients undergoing chemotherapy safely eat anchovies?
What is the appropriate heparin dosing regimen for treating a left ventricular thrombus?
Is it appropriate to reduce an adult patient who previously responded to 30 mg Adderall XR (mixed amphetamine salts) for two years but now has no effect at 60 mg total daily to a low‑dose 5 mg immediate‑release formulation, and what tapering schedule is recommended?
What are the diagnostic criteria for metabolic syndrome according to the ATP‑III (Adult Treatment Panel III) guidelines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.